STAT Plus: A drug that was once inexpensive gets a new price tag: $375,000
ADOBE
Catalyst Pharmaceuticals did not actually invent the drug, but spent the past several years testing a slightly modified version — and got FDA approval.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario